Erratum to: Safety of long-term denosumab therapy: results from the open label extension phase of two phase 3 studies in patients with metastatic breast and prostate cancer [Supportive Care in Cancer, (2015), DOI:10.1007/s00520-015-2904-5]

Alison T. Stopeck; Karim Fizazi; Jean Jacques Body; Janet E. Brown; Michael Carducci; Ingo Diel; Yasuhiro Fujiwara; Miguel Martín; Alexander Paterson; Katia Tonkin; Neal Shore; Paul Sieber; Frank Kueppers; Lawrence Karsh; Denise Yardley; Huei Wang; Tapan Maniar; Jorge Arellano; Ada Braun

doi:10.1007/s00520-015-2985-1

Erratum to: Safety of long-term denosumab therapy: results from the open label extension phase of two phase 3 studies in patients with metastatic breast and prostate cancer [Supportive Care in Cancer, (2015), DOI:10.1007/s00520-015-2904-5]

Alison T. Stopeck
, Karim Fizazi
, Jean Jacques Body
, Janet E. Brown
, Michael Carducci
, Ingo Diel
, Yasuhiro Fujiwara
, Miguel Martín
, Alexander Paterson
, Katia Tonkin
, Neal Shore
, Paul Sieber
, Frank Kueppers
, Lawrence Karsh
, Denise Yardley
, Huei Wang
, Tapan Maniar
, Jorge Arellano
, Ada Braun

University of Paris Sud
Brugmann University Hospital
Leeds Teaching Hospitals NHS Trust
University of Sheffield
Johns Hopkins University
Center for Comprehensive Gynecology Clinic
National Cancer Center Japan
Complutense University
Tom Baker Cancer Centre
Cross Cancer Institute
Carolina Urologic Research Center
Lancaster Urology
Urology Associates
The Urology Center of Colorado
Sarah Cannon Research Institute
Amgen Incorporated

Research output: Contribution to journal › Comment/debate

19 Scopus citations

Original language	English
Pages (from-to)	457-458
Number of pages	2
Journal	Supportive Care in Cancer
Volume	24
Issue number	1
DOIs	https://doi.org/10.1007/s00520-015-2985-1
State	Published - Jan 1 2016

Access to Document

10.1007/s00520-015-2985-1

Fingerprint

Dive into the research topics of 'Erratum to: Safety of long-term denosumab therapy: results from the open label extension phase of two phase 3 studies in patients with metastatic breast and prostate cancer [Supportive Care in Cancer, (2015), DOI:10.1007/s00520-015-2904-5]'. Together they form a unique fingerprint.

Cite this

Stopeck, A. T., Fizazi, K., Body, J. J., Brown, J. E., Carducci, M., Diel, I., Fujiwara, Y., Martín, M., Paterson, A., Tonkin, K., Shore, N., Sieber, P., Kueppers, F., Karsh, L., Yardley, D., Wang, H., Maniar, T., Arellano, J., & Braun, A. (2016). Erratum to: Safety of long-term denosumab therapy: results from the open label extension phase of two phase 3 studies in patients with metastatic breast and prostate cancer [Supportive Care in Cancer, (2015), DOI:10.1007/s00520-015-2904-5]. Supportive Care in Cancer, 24(1), 457-458. https://doi.org/10.1007/s00520-015-2985-1

Stopeck, Alison T. ; Fizazi, Karim ; Body, Jean Jacques et al. / Erratum to : Safety of long-term denosumab therapy: results from the open label extension phase of two phase 3 studies in patients with metastatic breast and prostate cancer [Supportive Care in Cancer, (2015), DOI:10.1007/s00520-015-2904-5]. In: Supportive Care in Cancer. 2016 ; Vol. 24, No. 1. pp. 457-458.

@article{90a8345fe0c04ce38e282265d217567a,

title = "Erratum to: Safety of long-term denosumab therapy: results from the open label extension phase of two phase 3 studies in patients with metastatic breast and prostate cancer [Supportive Care in Cancer, (2015), DOI:10.1007/s00520-015-2904-5]",

author = "Stopeck, \{Alison T.\} and Karim Fizazi and Body, \{Jean Jacques\} and Brown, \{Janet E.\} and Michael Carducci and Ingo Diel and Yasuhiro Fujiwara and Miguel Mart{\'i}n and Alexander Paterson and Katia Tonkin and Neal Shore and Paul Sieber and Frank Kueppers and Lawrence Karsh and Denise Yardley and Huei Wang and Tapan Maniar and Jorge Arellano and Ada Braun",

year = "2016",

month = jan,

day = "1",

doi = "10.1007/s00520-015-2985-1",

language = "English",

volume = "24",

pages = "457--458",

journal = "Supportive Care in Cancer",

issn = "0941-4355",

number = "1",

}

Stopeck, AT, Fizazi, K, Body, JJ, Brown, JE, Carducci, M, Diel, I, Fujiwara, Y, Martín, M, Paterson, A, Tonkin, K, Shore, N, Sieber, P, Kueppers, F, Karsh, L, Yardley, D, Wang, H, Maniar, T, Arellano, J & Braun, A 2016, 'Erratum to: Safety of long-term denosumab therapy: results from the open label extension phase of two phase 3 studies in patients with metastatic breast and prostate cancer [Supportive Care in Cancer, (2015), DOI:10.1007/s00520-015-2904-5]', Supportive Care in Cancer, vol. 24, no. 1, pp. 457-458. https://doi.org/10.1007/s00520-015-2985-1

Erratum to: Safety of long-term denosumab therapy: results from the open label extension phase of two phase 3 studies in patients with metastatic breast and prostate cancer [Supportive Care in Cancer, (2015), DOI:10.1007/s00520-015-2904-5]. / Stopeck, Alison T.; Fizazi, Karim; Body, Jean Jacques et al.
In: Supportive Care in Cancer, Vol. 24, No. 1, 01.01.2016, p. 457-458.

Research output: Contribution to journal › Comment/debate

TY - JOUR

T1 - Erratum to

T2 - Safety of long-term denosumab therapy: results from the open label extension phase of two phase 3 studies in patients with metastatic breast and prostate cancer [Supportive Care in Cancer, (2015), DOI:10.1007/s00520-015-2904-5]

AU - Stopeck, Alison T.

AU - Fizazi, Karim

AU - Body, Jean Jacques

AU - Brown, Janet E.

AU - Carducci, Michael

AU - Diel, Ingo

AU - Fujiwara, Yasuhiro

AU - Martín, Miguel

AU - Paterson, Alexander

AU - Tonkin, Katia

AU - Shore, Neal

AU - Sieber, Paul

AU - Kueppers, Frank

AU - Karsh, Lawrence

AU - Yardley, Denise

AU - Wang, Huei

AU - Maniar, Tapan

AU - Arellano, Jorge

AU - Braun, Ada

PY - 2016/1/1

Y1 - 2016/1/1

UR - https://www.scopus.com/pages/publications/84949087250

U2 - 10.1007/s00520-015-2985-1

DO - 10.1007/s00520-015-2985-1

M3 - Comment/debate

AN - SCOPUS:84949087250

SN - 0941-4355

VL - 24

SP - 457

EP - 458

JO - Supportive Care in Cancer

JF - Supportive Care in Cancer

IS - 1

ER -

Stopeck AT, Fizazi K, Body JJ, Brown JE, Carducci M, Diel I et al. Erratum to: Safety of long-term denosumab therapy: results from the open label extension phase of two phase 3 studies in patients with metastatic breast and prostate cancer [Supportive Care in Cancer, (2015), DOI:10.1007/s00520-015-2904-5]. Supportive Care in Cancer. 2016 Jan 1;24(1):457-458. doi: 10.1007/s00520-015-2985-1

Erratum to: Safety of long-term denosumab therapy: results from the open label extension phase of two phase 3 studies in patients with metastatic breast and prostate cancer [Supportive Care in Cancer, (2015), DOI:10.1007/s00520-015-2904-5]

Access to Document

Other files and links

Fingerprint

Cite this